Early finerenone for heart failure in hospital
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests if starting finerenone early helps patients hospitalized with heart failure who have symptoms like shortness of breath or swelling. It aims to see if the drug is safe and effective when given soon after admission.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are currently in the hospital for heart failure and need IV diuretics or vasodilators.
- You have new or worsening heart failure symptoms like shortness of breath, fatigue, or leg swelling.
- Your blood pressure is at least 100 mmHg and you are not in shock or on a breathing machine.
- Your heart function (LVEF) is 40% or higher from a test in the past year.
- You can take oral medication and have no planned dialysis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a medication called finerenone to see if it helps people hospitalized for heart failure live longer and have fewer heart-related problems. It may be an option for those with a certain type of heart failure where the heart's pumping strength is mildly reduced or normal.
This study tests whether a medication called finerenone can reduce scarring in the heart and improve heart function in people with heart failure who have ejection fractions of 40% or higher. You may be eligible if you've recently had heart failure symptoms requiring emergency care or medication changes.
This study tests whether finerenone, a new type of drug, can help people with heart failure who cannot take standard steroid-based MRAs (a kind of heart medication) because of side effects or other reasons. It aims to see if it improves symptoms and is safe for you.
This trial tests if a medication called finerenone can improve heart structure and function in people whose heart walls are thickened. It may help people with early heart failure or related conditions like diabetes or kidney disease.
This trial tests whether a medication called finerenone can help patients with heart failure who are having a minimally invasive procedure (TAVI) to replace a narrowed aortic valve. The goal is to see if this drug reduces heart problems after the valve procedure.
This trial tests how safe and effective finerenone is for adults with chronic heart failure. It includes people whose heart pumps blood with at least 40% efficiency.
Hear when a new Acute Heart Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.